Adicet Bio, Inc. is a clinical stage biotechnology company, which engages in discovering and developing allogeneic gamma delta T cell therapies for cancer. It also focuses on developing a pipeline of “off-the-shelf” gamma delta T cells. The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
102
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Adicet Bio Inc market cap is $20.03M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Adicet Bio Inc 52 week high is $11.15 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Adicet Bio Inc 52 week low is $2.12 as of November 22, 2026.
Adicet Bio Inc stock price today is $2.14.
Adicet Bio Inc stock price yesterday was $2.46.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Adicet Bio Inc's P/E ratio is -0.25.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Adicet Bio Inc P/B ratio is 0.1951.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Adicet Bio Inc 50-day moving average is $5.23.